http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011218817-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de09168142c4f96ceeaad5942598ecdf |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-20 |
filingDate | 2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa922902ed210f55219dedba2a2a475b |
publicationDate | 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2011218817-A1 |
titleOfInvention | Method for carrying out clinical studies and method for establishing a prognosis model for clinical studies |
abstract | A method for planning and carrying out clinical studies, wherein, during and after the end of a predetermined period, values of a predefined target criterion of control persons of a virtual control group are compared with values of the predefined target criterion of test persons of a test group which received a treatment to be investigated. The values of the predefined target criterion of the control persons of the virtual control group during and after the end of the predetermined period are determined from starting characteristics values assigned to the control persons. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016140322-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021057108-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113436140-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11636309-B2 |
priorityDate | 2008-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560821 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57339251 |
Total number of triples: 18.